Robert Safirstein

7.5k total citations · 2 hit papers
89 papers, 5.9k citations indexed

About

Robert Safirstein is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Robert Safirstein has authored 89 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 28 papers in Pathology and Forensic Medicine and 22 papers in Nephrology. Recurrent topics in Robert Safirstein's work include Chemotherapy-induced organ toxicity mitigation (25 papers), Renal and related cancers (20 papers) and Acute Kidney Injury Research (15 papers). Robert Safirstein is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (25 papers), Renal and related cancers (20 papers) and Acute Kidney Injury Research (15 papers). Robert Safirstein collaborates with scholars based in United States, China and Puerto Rico. Robert Safirstein's co-authors include István Arany, Judit Megyesi, Peter M. Price, Jonathan Winston, Joseph B. Guttenplan, Subodh J. Saggi, Zheng Dong, Man J. Livingston, Chengyuan Tang and Gary V. Désir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Robert Safirstein

88 papers receiving 5.8k citations

Hit Papers

Cisplatin nephrotoxicity 2003 2026 2010 2018 2003 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Safirstein United States 42 2.5k 2.2k 1.5k 986 605 89 5.9k
Ganesan Ramesh United States 37 2.1k 0.8× 2.8k 1.3× 1.4k 0.9× 693 0.7× 494 0.8× 66 6.4k
Judit Megyesi United States 36 1.8k 0.7× 1.2k 0.6× 1.3k 0.8× 609 0.6× 318 0.5× 69 4.1k
Wilfred Lieberthal United States 41 2.4k 0.9× 871 0.4× 1.7k 1.1× 318 0.3× 504 0.8× 79 5.9k
Naohiko Anzai Japan 46 2.9k 1.1× 803 0.4× 1.8k 1.2× 2.1k 2.1× 365 0.6× 213 6.8k
Qingqing Wei United States 36 2.7k 1.1× 1.3k 0.6× 1.8k 1.2× 290 0.3× 367 0.6× 85 5.5k
Navjotsingh Pabla United States 24 1.5k 0.6× 1.8k 0.8× 567 0.4× 871 0.9× 284 0.5× 48 3.8k
Takeshi Sugaya Japan 61 3.7k 1.4× 836 0.4× 3.4k 2.2× 676 0.7× 731 1.2× 229 10.7k
Hanna E. Abboud United States 57 3.7k 1.5× 752 0.3× 2.3k 1.5× 610 0.6× 645 1.1× 166 9.0k
Chengyuan Tang China 39 2.9k 1.1× 925 0.4× 1.8k 1.2× 237 0.2× 461 0.8× 100 6.1k
Seok Ho South Korea 34 2.0k 0.8× 655 0.3× 1.4k 0.9× 2.7k 2.7× 238 0.4× 79 6.1k

Countries citing papers authored by Robert Safirstein

Since Specialization
Citations

This map shows the geographic impact of Robert Safirstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Safirstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Safirstein more than expected).

Fields of papers citing papers by Robert Safirstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Safirstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Safirstein. The network helps show where Robert Safirstein may publish in the future.

Co-authorship network of co-authors of Robert Safirstein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Safirstein. A scholar is included among the top collaborators of Robert Safirstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Safirstein. Robert Safirstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xiaojia, Heino Velázquez, Richard Torres, et al.. (2019). Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease. Kidney International. 95(4). 797–814. 66 indexed citations
2.
Guo, Xiaojia, Heino Velázquez, John Chang, et al.. (2016). Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism. Cancer Research. 76(13). 3884–3894. 45 indexed citations
3.
Guo, Xiaojia, Douglas MacPherson, Ling Wang, et al.. (2016). Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Scientific Reports. 6(1). 22996–22996. 35 indexed citations
4.
Wang, Ling, Heino Velázquez, John Chang, Robert Safirstein, & Gary V. Désir. (2015). Identification of a Receptor for Extracellular Renalase. PLoS ONE. 10(4). e0122932–e0122932. 58 indexed citations
5.
Hu, Chang-Ping, Bum‐Yong Kang, Judit Megyesi, et al.. (2009). Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney International. 76(5). 521–527. 31 indexed citations
6.
Arany, István, et al.. (2007). Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells. American Journal of Physiology-Renal Physiology. 294(3). F577–F581. 40 indexed citations
7.
Portilla, Didier, Kiran K. Nagothu, Judit Megyesi, et al.. (2006). Metabolomic study of cisplatin-induced nephrotoxicity. Kidney International. 69(12). 2194–2204. 142 indexed citations
8.
Arany, István, Judit Megyesi, Barry D. Nelkin, & Robert Safirstein. (2006). STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney International. 70(4). 669–674. 54 indexed citations
9.
Yu, Fang, Judit Megyesi, Robert Safirstein, & Peter M. Price. (2005). Identification of the functional domain of p21WAF1/CIP1that protects cells from cisplatin cytotoxicity. American Journal of Physiology-Renal Physiology. 289(3). F514–F520. 60 indexed citations
10.
Price, Peter M., Judit Megyesi, & Robert Safirstein. (2004). Cell cycle regulation: Repair and regeneration in acute renal failure. Kidney International. 66(2). 509–514. 35 indexed citations
11.
Arany, István, Judit Megyesi, Hideaki Kaneto, Peter M. Price, & Robert Safirstein. (2004). Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. American Journal of Physiology-Renal Physiology. 287(3). F543–F549. 193 indexed citations
12.
Rice, James, et al.. (2002). MONOCYTE CHEMOATTRACTANT PROTEIN-1 EXPRESSION CORRELATES WITH MONOCYTE INFILTRATION IN THE POST-ISCHEMIC KIDNEY. Renal Failure. 24(6). 703–723. 47 indexed citations
13.
Megyesi, Judit, et al.. (2001). Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney International. 60(6). 2164–2172. 113 indexed citations
14.
Mari, John F. Di, Roger J. Davis, & Robert Safirstein. (1999). MAPK activation determines renal epithelial cell survival during oxidative injury. American Journal of Physiology-Renal Physiology. 277(2). F195–F203. 171 indexed citations
15.
Saggi, Subodh J., Robert Safirstein, & Peter M. Price. (1992). Cloning and Sequencing of the Rat Preproepidermal Growth Factor cDNA: Comparison with Mouse and Human Sequences. DNA and Cell Biology. 11(6). 481–487. 41 indexed citations
16.
Winston, Jonathan, et al.. (1989). Glomerular hemodynamics in cyclosporine nephrotoxicity following uninephrectomy. Kidney International. 35(5). 1175–1182. 13 indexed citations
17.
Moel, Donald I., Robert Safirstein, Robert C. McEvoy, & Willa A. Hsueh. (1987). Effect of aspirin on experimental diabetic nephropathy.. PubMed. 110(3). 300–7. 41 indexed citations
18.
Winston, Jonathan & Robert Safirstein. (1985). Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. American Journal of Physiology-Renal Physiology. 249(4). F490–F496. 171 indexed citations
19.
Safirstein, Robert, et al.. (1982). Renal transport and biotransformation of cisplatin (P). Kidney International. 21(1). 1 indexed citations
20.
Safirstein, Robert, et al.. (1981). Renal disposition and metabolism of liganded platinum (PT): Implications to toxicity. Federation Proceedings. 40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026